Cardiac arrest (CA) is one of the main causes of mortality and long-term neurological disability in the world, and survivors often have post-resuscitation brain injury that is defined by cognitive impairments, encephalopathy, and lack of functional recovery1,2. Timely detection of patients at risk of adverse neurological outcomes is necessary in the right direction to inform therapeutic interventions, prognostic counseling, and intensive care resources. Nevertheless, prognostic tools currently in use, such as the neurological examination, serum biomarkers, such as neuron-specific enolase, and neuroimaging, such as computed tomography (CT) and magnetic resonance imaging (MRI), have significant limitations of latency, low sensitivity or specificity, high cost, and infeasibility in continuous bedside use3,4,5.
The combined objective of this methodology is to develop a standardized, reproducible, non-invasive, bedside technique of measuring intracranial dynamics by using the ultrasound-measured optic nerve sheath diameter (ONSD) and to determine its capacity to predict cognitive dysfunction in post-resuscitation intensive care unit (ICU) patients. The reasoning behind ONSD implementation is that there is an anatomical continuity between the optic nerve sheath and the intracranial subarachnoid space so that alterations occurring in intracranial pressure (ICP) can be passed over to the optic nerve sheath and measured with ultrasonography6,7. Since Cerebral edema and increased ICP are closely related to post-cardiac arrest brain injury, ONSD measurement is a physiologically applicable surrogate endpoint of early neurological impairment.
The ONSD assessment using ultrasound has a number of distinct advantages as compared to alternative methods. In comparison with invasive ICP monitoring, it means the absence of complications of the procedure (infection or hemorrhage). Compared to CT and MRI, it can be performed at the bedside, is repeatable, inexpensive, portable, and does not require radiation or the transportation of the patient. Further, ONSD measurement makes it possible to monitor dynamically and serially, which is especially helpful in patients with unstable neurological states who are critically ill and have a rapidly changing condition8,9,10. Past research has shown that ONSD is strongly correlated with high ICP and is a prognostic factor in patients with traumatic brain injuries and post-cardiac arrests11,12. Nevertheless, the imprecision of measurement methods and the absence of unified procedures have contributed to its absence in clinical use.
In the larger literature, ONSD is now being identified as an accurate non-invasive biomarker of intracranial hypertension, with systematic reviews and meta-analyses showing good diagnostic accuracy in measuring elevated ICP13,14,15. However, it has not been comprehensively studied as a predictor of cognitive impairment after resuscitation, especially when it comes to serial measures and standard methods of acquisition.
This approach is especially applicable to clinicians in emergency and critical care environments in need of a fast, reproducible, non-invasive instrument to evaluate early neurological status. It is particularly useful in cases where sophisticated neuroimaging or invasive monitoring is not easily available and practicable. Nevertheless, accurate training of the operator, following standardized measurement procedures, and taking into account confounding factors, including orbital pathology or edema, is necessary to achieve measurement accuracy and reproducibility. Thus, the aim of the study is to standardize the use of ultrasound-based ONSD and determine its clinical potential as a bedside prognostic variable assessing the predictability of cognitive impairment in post-resuscitation ICU patients.